13th September,2025 The Government of India has just announced a significant change that will impact the pharmaceutical and medical devices industry, effective “22nd September 2025”. Yes, you read that right—GST rates on drugs, formulations, and medical devices are being reduced,…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
